Friday, May 13, 2016

What Awaits These Phase 3 Trials - Guaranteed Success Or Costly Disappointment?

Drug companies spend billions on R&D, which is the lifeline of the pharma industry. According to a report published by the Tufts Center for the Study of Drug Development, it costs about $2.6 billion to develop a new drug and bring it to market.

from RTT - Biotech http://ift.tt/1UYhPNx
via IFTTT

No comments:

Post a Comment